These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

481 related items for PubMed ID: 25257673

  • 21. [Methylprednisolone pulse therapy in Kawasaki disease].
    Miura M, Matsuoka M, Kohno K, Ohki H, Yoshiba S.
    Nihon Rinsho; 2008 Feb; 66(2):338-42. PubMed ID: 18265457
    [Abstract] [Full Text] [Related]

  • 22. Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions: Is Dual Therapy More Effective?
    Jone PN, Anderson MS, Mulvahill MJ, Heizer H, Glodé MP, Dominguez SR.
    Pediatr Infect Dis J; 2018 Oct; 37(10):976-980. PubMed ID: 29461447
    [Abstract] [Full Text] [Related]

  • 23. Neutropenia after intravenous immunoglobulin therapy is associated with coronary artery lesions in children with Kawasaki disease: a case control study.
    Wang Z, Weng F, Li C, Shi H, Tang Z, Qiu H, He Y, Wu R, Chu M.
    BMC Pediatr; 2018 Feb 21; 18(1):76. PubMed ID: 29466965
    [Abstract] [Full Text] [Related]

  • 24. The role of serum lipid in predicting coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease: a cohort study.
    Zhang H, Cai J, Zhang R, Shuai S, Tang M, Ju R, Hu Y, Zuo T, Yang Y.
    J Int Med Res; 2024 May 21; 52(5):3000605241252115. PubMed ID: 38713460
    [Abstract] [Full Text] [Related]

  • 25. Coronary artery lesions and the increasing incidence of Kawasaki disease resistant to initial immunoglobulin.
    Kibata T, Suzuki Y, Hasegawa S, Matsushige T, Kusuda T, Hoshide M, Takahashi K, Okada S, Wakiguchi H, Moriwake T, Uchida M, Ohbuchi N, Iwai T, Hasegawa M, Ichihara K, Yashiro M, Makino N, Nakamura Y, Ohga S.
    Int J Cardiol; 2016 Jul 01; 214():209-15. PubMed ID: 27070994
    [Abstract] [Full Text] [Related]

  • 26. Correlations of complication with coronary arterial lesion with VEGF, PLT, D-dimer and inflammatory factor in child patients with Kawasaki disease.
    Zhou Y, Wang S, Zhao J, Fang P.
    Eur Rev Med Pharmacol Sci; 2018 Aug 01; 22(16):5121-5126. PubMed ID: 30178831
    [Abstract] [Full Text] [Related]

  • 27. Clinical relevance of the risk factors for coronary artery lesions in Kawasaki disease.
    Weng KP, Hsieh KS, Huang SH, Ou SF, Ma CY, Ho TY, Lai CR, Ger LP.
    Kaohsiung J Med Sci; 2012 Jan 01; 28(1):23-9. PubMed ID: 22226058
    [Abstract] [Full Text] [Related]

  • 28. Association of Genetic Polymorphisms in Kawasaki Disease with the Response to Intravenous Immunoglobulin Therapy.
    Sapountzi E, Fidani L, Giannopoulos A, Galli-Tsinopoulou A.
    Pediatr Cardiol; 2023 Jan 01; 44(1):1-12. PubMed ID: 35908117
    [Abstract] [Full Text] [Related]

  • 29. [Risk factors for coronary artery lesions secondary to Kawasaki disease in children].
    Deng YC, Wang X, Tang XC, Huang CZ, Yang J, Mo LY.
    Zhongguo Dang Dai Er Ke Za Zhi; 2015 Sep 01; 17(9):927-31. PubMed ID: 26412172
    [Abstract] [Full Text] [Related]

  • 30. Timing of intravenous immunoglobulin treatment and risk of coronary artery abnormalities in children with Kawasaki disease.
    Bal AK, Prasad D, Umali Pamintuan MA, Mammen-Prasad E, Petrova A.
    Pediatr Neonatol; 2014 Oct 01; 55(5):387-92. PubMed ID: 24636168
    [Abstract] [Full Text] [Related]

  • 31. Kawasaki disease in Sicily: clinical description and markers of disease severity.
    Maggio MC, Corsello G, Prinzi E, Cimaz R.
    Ital J Pediatr; 2016 Nov 02; 42(1):92. PubMed ID: 27806720
    [Abstract] [Full Text] [Related]

  • 32. [Plasma exchange therapy for Kawasaki disease refractory to intravenous immunoglobulin].
    Mori M.
    Nihon Rinsho; 2008 Feb 02; 66(2):349-54. PubMed ID: 18260334
    [Abstract] [Full Text] [Related]

  • 33. [Changes of P-selectin and E-selectin in children with Kawasaki disease].
    Qiu Y, Wu J, Fang XY, Lin Z, Wu BY, Cai RY, Xu XY, Zheng H.
    Zhonghua Er Ke Za Zhi; 2004 Sep 02; 42(9):688-92. PubMed ID: 15482673
    [Abstract] [Full Text] [Related]

  • 34. Acute and late coronary outcomes in 1073 patients with Kawasaki disease with and without intravenous γ-immunoglobulin therapy.
    Lin MT, Sun LC, Wu ET, Wang JK, Lue HC, Wu MH.
    Arch Dis Child; 2015 Jun 02; 100(6):542-7. PubMed ID: 25564534
    [Abstract] [Full Text] [Related]

  • 35. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
    Kuo HC, Lo MH, Hsieh KS, Guo MM, Huang YH.
    PLoS One; 2015 Jun 02; 10(12):e0144603. PubMed ID: 26658843
    [Abstract] [Full Text] [Related]

  • 36. [Therapeutic effectiveness of intravenous immunoglobulin at 1 g/kg and 2 g/kg on Kawasaki disease: a comparative and follow-up study].
    Qin LJ, Wang HW, Hu XF, Liu QJ, Shi H, Wei YX, Chen QJ, Cheng PX.
    Zhonghua Er Ke Za Zhi; 2006 Dec 02; 44(12):891-5. PubMed ID: 17254453
    [Abstract] [Full Text] [Related]

  • 37. Increased Pentraxin 3 Levels Correlate With IVIG Responsiveness and Coronary Artery Aneurysm Formation in Kawasaki Disease.
    Kitoh T, Ohara T, Muto T, Okumura A, Baba R, Koizumi Y, Yamagishi Y, Mikamo H, Daigo K, Hamakubo T.
    Front Immunol; 2021 Dec 02; 12():624802. PubMed ID: 33912155
    [Abstract] [Full Text] [Related]

  • 38. Serum albumin level predicts initial intravenous immunoglobulin treatment failure in Kawasaki disease.
    Kuo HC, Liang CD, Wang CL, Yu HR, Hwang KP, Yang KD.
    Acta Paediatr; 2010 Oct 02; 99(10):1578-83. PubMed ID: 20491705
    [Abstract] [Full Text] [Related]

  • 39. Treatment of Kawasaki disease with a moderate dose (1 g/kg) of intravenous immunoglobulin.
    Khowsathit P, Hong-Hgam C, Khositseth A, Wanitkun S.
    J Med Assoc Thai; 2002 Nov 02; 85 Suppl 4():S1121-6. PubMed ID: 12549785
    [Abstract] [Full Text] [Related]

  • 40. Long-term efficacy of plasma exchange treatment for refractory Kawasaki disease.
    Hokosaki T, Mori M, Nishizawa T, Nakamura T, Imagawa T, Iwamoto M, Yokota S.
    Pediatr Int; 2012 Feb 02; 54(1):99-103. PubMed ID: 22004042
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.